European Business
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
European Business
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
European Business
No Result
View All Result
Home < INDUSTRIES Health

Sandoz announces agreement to acquire GSK’s cephalosporin antibiotics business, reinforcing its leading global position in antibiotics

by Marie Weil
February 12, 2021
A A
Share on LinkedinShare on Twitter
  • Sandoz to acquire three established brands sold in more than 100 markets
  • Acquisition, including leading global brand Zinnat®, confirms Sandoz commitment to antibiotics, following plans to expand its integrated manufacturing site in Kundl
  • Transaction complements Sandoz leadership in generic penicillins with a leading position in cephalosporins – largest antibiotic segment by global sales

Basel, February 11, 2021 – Sandoz, a Novartis division, has signed an agreement to acquire GSK’s cephalosporin antibiotics business, reinforcing its leading global position in antibiotics.

The agreement includes the global rights to three established brands (Zinnat®, Zinacef® and Fortum®)) in more than 100 markets. It excludes the rights in the US, Australia and Germany to certain of those brands, which were previously divested by GSK, and in India, Pakistan, Egypt, Japan (to certain of the brands) and China, which will be retained by GSK.

Sandoz will pay GSK USD 350 million at closing, plus additional milestone payments of up to USD 150 million, subject to the terms of the transaction. Closing of the transaction is expected in the second half of 2021, subject to customary closing conditions including regulatory approvals. In 2020, the three brands had combined sales of approximately USD 140 million in the relevant markets.

In line with its integrated manufacturing strategy, Sandoz intends in the longer term to manufacture Zinnat® at sites in its own network, which has global antibiotics production centered on its lead production site in Kundl, Austria. Once the transaction is completed, GSK will supply Zinnat® to Sandoz under a manufacturing and supply agreement (MSA), while supporting a transfer of the related manufacturing operations to Sandoz. We expect this process to last for approximately four years from the close of the transaction onwards.

“This important transaction will further position Sandoz as a global leader in antibiotics – truly essential medicines that are the backbone of modern healthcare systems,” said Sandoz CEO Richard Saynor.

“Cephalosporins are the largest antibiotic segment by global sales and acquiring this leading business, including the established global Zinnat® brand, will complement our #1 position in generic penicillins, the other key segment. It will also set us up for additional synergies driven by an increased promotional footprint that will support growth of both the acquired brands and the current existing Sandoz portfolio.”

The agreement confirms the Sandoz commitment to further grow its antibiotics business, following the announcement last year of a joint investment with the Austrian government of more than EUR 150 million to strengthen the long-term competitiveness of its Kundl antibiotic manufacturing site and help to ensure long-term supply resilience.

Kundl is the hub and center of the last major integrated production chain for antibiotics in the western world. Its focus is on generic penicillin products, but the plant also produces finished dosage forms of several generic cephalosporin products.

Tags: < Invest

Related Industries

Health

AstraZeneca announces new strategic collaboration with insitro to use advanced AI systems to develop transformative therapeutics for difficult to treat cardiometabolic diseases

October 16, 2026
Health

Boehringer Ingelheim investments into sustainability-related programs and health partnerships to reach EUR 500 million

September 30, 2026
Health

Philips-led projects win ITEA awards for advancing AI-enabled healthcare innovation

September 17, 2026
Health

Sanofi and Cheplapharm to create new strategic partnership in mature medicines

September 15, 2026
Health

Exor and Philips Extend Long-term Relationship Agreement

August 11, 2026
Health

Vanderbilt Health and Siemens Healthineers Launch $87M Value Partnership to Deliver Advanced Technology, Elevate Patient Care

July 28, 2026

DHL Group plans more than EUR 400 million investment to support growth and supply chain resilience in Central and Eastern Europe

October 9, 2026

...

Hilton and Scandic Sign New Nordics Strategic Agreement

October 20, 2026

...

Siemens partners with NVIDIA to advance AI-driven, autonomous factories

October 20, 2026

...

AkzoNobel and Axalta to be called Axanzo following merger

October 16, 2026

...

Volvo Cars and NVIDIA expand partnership to advance safe automated driving

October 16, 2026

...

AstraZeneca announces new strategic collaboration with insitro to use advanced AI systems to develop transformative therapeutics for difficult to treat cardiometabolic diseases

October 16, 2026

...

“Invest in Germany Summit”: Amazon Announces 16 Billion Euro Investment in Germany in 2027

October 21, 2026

...

ZEISS acquires Ceres Holographics to accelerate holography industrialization

October 9, 2026

...

IBM and Siemens Collaborate on Research to Advance Nanostack Architecture

October 15, 2026

...

IHG Hotels & Resorts hits 1,000 open hotels in Europe

October 23, 2026

...

European Business European Business European Business

EUROPEAN BUSINESS is a premier source of corporate news, business information and insights across broad spectrum of industries in Europe and worldwide.  We are one of the members of the Business World Network.

RESOURCES

  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS

CONTACT US

EDITORIAL:     editor # european-biz.com

PARTNERSHIP:     partnership # european-biz.com

HUMAN RESOURCE:     hr # european-biz.com

* (replace # with @)

  • Official Site

Copyright © EUROPEAN-BIZ.COM All rights reserved.

No Result
View All Result
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS

Copyright © EUROPEAN-BIZ.COM All rights reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist